Giancarlo Pruneri, MD, University of Milan, Milan, Italy, talks on the Molecular Tumor Board, a multidisciplinary team that discuss results generated by Next-Generation Sequencing (NGS) to govern precision oncology. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.